ABIN2869350
antibody from antibodies-online
		Targeting: NCOR1
		
		hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1	
	
	
	
	
Antibody data
- Antibody Data
 - Antigen structure
 - References [2]
 - Comments [0]
 - Validations
 - Western blot [1]
 - Immunohistochemistry [1]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - ABIN2869350 - Provider product page

 - Provider
 - antibodies-online
 - Product name
 - anti-Nuclear Receptor Co-Repressor 1 (NCOR1) (AA 1-192) antibody
 - Antibody type
 - Monoclonal
 - Description
 - Ascitic fluid
 - Reactivity
 - Human
 - Host
 - Mouse
 - Epitope
 - AA 1-192
 - Isotype
 - IgG
 - Antibody clone number
 - 7A7A9
 - Vial size
 - 100 μL
 - Storage
 - Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
 
Submitted references		Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo.
				
JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
				
		
	
			Atsumi A, Tomita A, Kiyoi H, Naoe T
Biochemical and biophysical research communications 2006 Jul 14;345(4):1471-80
		Biochemical and biophysical research communications 2006 Jul 14;345(4):1471-80
JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
			Zhang D, Yoon HG, Wong J
Molecular and cellular biology 2005 Aug;25(15):6404-14
		Molecular and cellular biology 2005 Aug;25(15):6404-14
				No comments: Submit comment	
	
			
							
					Supportive validation
					
									
				
				- Submitted by
 - antibodies-online (provider)
 - Main image
 
- Experimental details
 - WB
 
							
					Supportive validation
					
									
				
		- Submitted by
 - antibodies-online (provider)
 - Main image
 
- Experimental details
 - IHC